Phase II Study of Perindopril and Regorafenib in mCRC

Clinical trial NCT02651415 · COMPLETED

Trial details

NCT number: NCT02651415
Sponsor: British Columbia Cancer Agency
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2016-08-01
Primary completion: 2018-03-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.